AUSTRALIAN PRODUCT INFORMATION (ChAdOx1-S) …

As with other vaccines, the benefits and potential risks of vaccinating individuals with COVID-19 Vaccine AstraZeneca should be considered. Immunocompromised individuals The immunogenicity, efficacy and safety of COVID-19 Vaccine AstraZeneca has not been assessed in immunocompromised individuals, including those receiving immunosuppressive therapy.

  Information, Product, Should, Vaccine, Product information, Astrazeneca, Astrazeneca should